(PharmaNewsWire.Com, June 13, 2019 ) According to the new market research Blood Gas Analyzer Market is expected to reach USD 636.0 Million by 2021, at a CAGR of 4.6% during the forecast period of 2016 to 2021. The growth in blood gas analyzer market is majorly attributed to the rising demand for automated and point-of-care blood gas analyzer devices. These analyzers offer rapid analysis and are easy to use, portable, and offer short turnaround times, which make them valuable tools for managing oxygenation and ventilation of patients in ICUs and emergency departments. Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=242278963 The blood gas analyzer market is segmented on the basis of major product brands (i-STAT, epoc, GEM 3000, GEM 3500, GEM 4000, ABL800, ABL80, ABL90, cobas b 221, cobas b 121, cobas b 123, RAPID Series) in four major regional segments, namely, North America, Europe, APAC, and Rest of the World. The rising demand for point-of-care analyzers is another major factor driving the growth of the blood gas analyzer market. Products such as epoc, ABL90, cobas b 123, and GEM 4000 are expected to grow at high CAGRs during the forecast period (2016-2021) owing to advantages such as portability and faster turnaround times offered by them. In the near future, the commercialization of innovative POC blood gas analyzers based on miniaturized sensors will emerge as a significant opportunity, since the use of next-generation blood gas analyzers will reduce both cost and time involved in processes. The introduction of new-generation blood gas analyzers based on advanced sensors and the growing need for blood gas analyzers that are compatible with electronic medical record systems are some of the major factors expected to support market growth in the coming years. Download Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=242278963 Leading players in blood gas analyzer market are focusing on the launch of new and improved products as their key growth strategy. The major players in the global blood gas analyzer market are Abbott Laboratories (U.S.), Alere, Inc. (U.S.), Instrumentation Laboratory (U.S.), Radiometer (Denmark), Roche Diagnostics (Switzerland), and Siemens Healthcare (Germany). The top 3 companies’ together account for a share of more than 70% of the global market. These players have adopted several strategies to remain competitive in this space. Enhancement of existing products, development of new products, collaborations and agreements are among the top strategies adopted by the leading companies in blood gas analyzers market.
Contact: Mr. Shelly Singh MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: sales@marketsandmarkets.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
